SMTL ID : 6o6g.1

Co-crystal structure of Mcl1 with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x LOJ: (3S)-5-(cyclobutylmethyl)-3-(2,4-dichlorophenyl)-2,3,4,5-tetrahydro-1,5-benzoxazepine-7-carboxylic acid(Non-covalent)

LOJ.1: 13 residues within 4Å: Chain A: A.56, F.57, M.60, L.75, M.79, V.82, F.83, R.92, L.96, F.99, G.100, V.103, L.119 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.57, A:M.60, A:M.79, A:V.82, A:L.96, A:F.99 Salt bridges: A:R.92 pi-Stacking: A:F.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Caenepeel, S. et al., AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. Cancer Discov (2018)

Release Date

2019-05-15

Peptides

Induced myeloid leukemia cell differentiation protein Mcl-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Induced myeloid leukemia cell differentiation protein Mcl-1

Related Entries With Identical Sequence